Phase II Trial Of Neoadjuvant Bevacizumab With Modified FOLFOX7 In Patients With Stage II And III Rectal Cancer
Phase of Trial: Phase II
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Rectal cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 11 Apr 2017 Planned End Date changed from 1 Jul 2017 to 2 Aug 2019.
- 11 Apr 2017 Planned primary completion date changed from 1 Jul 2016 to 2 Aug 2018.